Fore Biotherapeutics

Fore Biotherapeutics is a precision oncology company pioneering the development of cancer therapies guided by functional genomics, aiming to develop treatments for genetically defined cancer patients who currently have limited treatment options. To address unmet needs across diverse patient populations, Fore Biotherapeutics has developed a unique AI-supported drug discovery approach that accurately identifies oncogenic yet undruggable mutations and then matches them with potential drug candidates in a tumor-agnostic manner.